In the near future, the CBD, THC or other cannabinoids you consume in edibles or medications may not be derived from cannabis at all, but grown in a laboratory.
Kevin Chen, CEO and co-founder of Hyasynth Bio, describes the Montreal-based start-up as "focused on engineering strains of yeast to produce the active compounds of cannabis without having to grow plants."
Recent comments
6 hours 39 min ago
5 days 14 hours ago
10 weeks 5 days ago
14 weeks 6 days ago
15 weeks 6 days ago
15 weeks 6 days ago
37 weeks 2 hours ago
41 weeks 1 day ago
42 weeks 5 days ago
42 weeks 6 days ago